ES8400441A1 - "procedimiento para la produccion de 1-azaxantona". - Google Patents

"procedimiento para la produccion de 1-azaxantona".

Info

Publication number
ES8400441A1
ES8400441A1 ES515897A ES515897A ES8400441A1 ES 8400441 A1 ES8400441 A1 ES 8400441A1 ES 515897 A ES515897 A ES 515897A ES 515897 A ES515897 A ES 515897A ES 8400441 A1 ES8400441 A1 ES 8400441A1
Authority
ES
Spain
Prior art keywords
azaxanthone
processes
production
pharmaceutical compositions
therapeutic agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES515897A
Other languages
English (en)
Other versions
ES515897A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Lacer SA
Original Assignee
Lacer SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lacer SA filed Critical Lacer SA
Publication of ES8400441A1 publication Critical patent/ES8400441A1/es
Publication of ES515897A0 publication Critical patent/ES515897A0/es
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79—Acids; Esters
    • C07D213/80—Acids; Esters in position 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/61—Halogen atoms or nitro radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/89—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Diabetes (AREA)
  • Rheumatology (AREA)
  • Hematology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Cephalosporin Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

PROCEDIMIENTO PARA LA OBTENCION DE 1-AZAXANTONA.CONSISTE EN LA REACCION DE CICLIZACION DE ACIDO 2-FENOXINICOTINICO POR CALENTAMIENTO A UNA TEMPERATURA ENTRE 160JC Y 200JC EN PRESENCIA DE ACIDO POLIFOSFORICO COMO AGENTE DESHIDRATANTE. LA REACCION SE LLEVA A CABO AÑADIENDO EL ACIDO 2-FENOXINICOTINICO SOBRE 5-10 VECES SU PESO DE ACIDO POLIFOSFORICO DE 80-85, EXPRESADO EN P2O5, PREVIAMENTE CALENTADO. LA MEZCLA DE REACCION SE DILUYE CON AGUA, SE NEUTRALIZA HASTA PH 2-3 CON ALCALI Y SE SEPARA DE LA 1-AZAXANTONA.LA 1-AZAXANTONA TIENE APLICACIONES FARMACOLOGICAS POR SU ACTIVIDAD ANALGESICA, ANTIPIRETICA,ANTIINFLAMATORIA, ESPASMOLITICA, BRONCODILATADORA Y DIURETICA.
ES515897A 1981-09-25 1982-09-23 "procedimiento para la produccion de 1-azaxantona". Granted ES515897A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP81107651A EP0075607B1 (en) 1981-09-25 1981-09-25 1-azaxanthone for use as therapeutic agent, processes for its production and pharmaceutical compositions

Publications (2)

Publication Number Publication Date
ES8400441A1 true ES8400441A1 (es) 1983-11-16
ES515897A0 ES515897A0 (es) 1983-11-16

Family

ID=8187931

Family Applications (2)

Application Number Title Priority Date Filing Date
ES515898A Granted ES515898A0 (es) 1981-09-25 1982-09-23 "procedimiento para la produccion de 1-azaxantona".
ES515897A Granted ES515897A0 (es) 1981-09-25 1982-09-23 "procedimiento para la produccion de 1-azaxantona".

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES515898A Granted ES515898A0 (es) 1981-09-25 1982-09-23 "procedimiento para la produccion de 1-azaxantona".

Country Status (7)

Country Link
US (1) US4623648A (es)
EP (1) EP0075607B1 (es)
JP (1) JPS5867618A (es)
AT (1) ATE12072T1 (es)
DE (1) DE3169269D1 (es)
ES (2) ES515898A0 (es)
PT (2) PT75582A (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1200085B (it) * 1984-07-12 1989-01-05 Sandoz Ag Procedimento per la preparazione di xantoni e di tioxantoni
US5565413A (en) * 1994-12-06 1996-10-15 Zeneca Limited Substituted pyridyl phenyl ketone herbicides
BR9808136A (pt) * 1997-03-03 2000-03-28 Sanofi Synthelabo Formulações farmacêuticas contendo substâncias medicamentosas fracamente solúveis.
CA2450073C (en) 2001-07-25 2017-08-29 Biomarin Pharmaceutical Inc. Compositions and methods for modulating blood-brain barrier transport
EP2671508B1 (en) 2005-04-28 2020-09-16 Proteus Digital Health, Inc. Pharma-informatics system
JP2010503710A (ja) 2006-09-18 2010-02-04 ラプトール ファーマシューティカル インコーポレイテッド 受容体関連タンパク質（ｒａｐ）結合体の投与による肝障害の処置
ES2919563T3 (es) 2009-02-20 2022-07-27 Enhanx Biopharm Inc Sistema de administración de medicamentos a base de glutatión
KR20180114970A (ko) 2009-05-06 2018-10-19 라보라토리 스킨 케어, 인크. 활성제-칼슘 포스페이트 입자 복합체를 포함하는 피부 전달 조성물 및 이들을 이용하는 방법
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3803153A (en) 1970-11-16 1974-04-09 Schering Corp Benzopyrano pyridines
JPS5619350B2 (es) * 1972-07-21 1981-05-07
JPS5919113B2 (ja) * 1975-02-03 1984-05-02 ウェルファイド株式会社 新規なベンゾピラノピリジン誘導体の製法
JPS5195097A (ja) * 1975-02-08 1976-08-20 Benzopiranopirijinjudotainoseizoho

Also Published As

Publication number Publication date
PT75581A (fr) 1982-10-01
PT75582A (fr) 1982-10-01
JPS5867618A (ja) 1983-04-22
ATE12072T1 (de) 1985-03-15
US4623648A (en) 1986-11-18
DE3169269D1 (en) 1985-04-18
ES8308886A1 (es) 1983-10-16
JPH0354645B2 (es) 1991-08-20
EP0075607B1 (en) 1985-03-13
PT75581B (fr) 1985-05-31
ES515897A0 (es) 1983-11-16
ES515898A0 (es) 1983-10-16
EP0075607A1 (en) 1983-04-06

Similar Documents

Publication Publication Date Title
ES8203390A1 (es) Un procedimiento de preparacion de un material cambiador de ion de celulosa carboxilada
PT75582A (fr) Procede de preparation de 1-azaxantone
FR2428025B1 (es)
SE7703617L (sv) Forfarande for framstellning av 2-klornikotinsyra
ES8105304A1 (es) Procedimiento para la obtencion de acido cianurico puro
ES508421A0 (es) "procedimiento para la preparacion de cloruro de 2-hidroxi-3-cloropropiltrialcohilamonio".
JPS5673081A (en) Preparation of tocopherol acetate
SE8502859D0 (sv) Forfarande for framstellning av ett vermeisolerande material
DK551384D0 (da) Lorazepamholdigt sovemiddel og fremgangsmaade til dets fremstilling
SU598865A1 (ru) "Способ получени 13-кетобицикло (10,3,0)-1
SU662517A1 (ru) Газообразный реагент дл обработки стекла
SU381655A1 (ru) Сырьевая смесь для получения теплоизоляционного
ES8605666A1 (es) Procedimiento de preparar concentrados proteicos y preparaciones alimenticias.
GB1491649A (en) Process for the preparation of bromoacetic acid and esters thereof
ES259139A1 (es) Metodo de preparaciën de n-metalacridona
JPS5687556A (en) Preparation of aziridine-2-carboxylate
JPS57102875A (en) 5-acylamino-4-methyloxazole and its preparation
ES320115A1 (es) Procedimiento para la preparaciën de dicloropiracinas
SU1483883A1 (ru) Хлористые соли (3-хлор-5-алкокси-2-пентен)ил-хинолиния как ингибиторы кислотной коррозии
JPS54151195A (en) Production of phenylphenol
GB759316A (en) Improvements in and relating to derivatives of purine
SE7602395L (sv) Nytt sett att framstella 2-guanidinometyl-perhydroazocinsulfat
GB1116126A (en) Process for the preparation of a mercapto-thiophosphoric acid ester
SU1297279A1 (ru) Способ получения эфирного масла, обладающего ранозаживляющей и противовоспалительной активностью
ES8200091A1 (es) Procedimiento para la produccion de n-((2s)-3-mercapto-2-me-tilpropionil)-l-prolina

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19970519